POSB259 Immuno-Oncology Treatments: Key Factors Influencing NICE Approval, 2011-2020

Abstract

Authors

A Pagotto V Kontogiannis D Gonçalves-Bradley K Chalmers B Langford C Rinciog L Sawyer A Diamantopoulos

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×